Filing Flows › Utah Medical Products (UTMD) › Q4 2024
Utah Medical Products (UTMD) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 26, 2025
Utah Medical Products (UTMD) reported revenue of $9.2M for the fourth quarter 2024 (Q4 2024), -26% from a year earlier and -8% from the quarter before. Operating margin was 32.0%, net earnings $2.9M (31.7% of revenue).
Utah Medical Products, Q4 2024: revenue $9.2M (-26% year over year), operating margin 32.0%, net earnings $2.9M, operating cash flow $2.9M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.2M | -8% | -26% |
| Gross profit | $5.3M | -8% | -25% |
| Operating profit | $2.9M | -12% | -26% |
| Net earnings | $2.9M | -19% | -32% |
| Operating cash flow | $2.9M | -24% | -45% |
| Free cash flow | $2.9M | -22% | -44% |
What changed
Revenue was $9.2M in Q4 2024, down 26% year over year and down 8% from the previous quarter.
Gross margin was 58.1%, up 0.6 points from a year earlier. Operating profit was $2.9M, a 32.0% margin (unchanged year over year). Operating expenses fell 24% while revenue fell 26%. Net earnings were $2.9M, down 32% year over year. The effective tax rate was 19.7%.
Operating cash flow was $2.9M (down 45% year over year), 101% of net earnings. Non-cash charges added back $717K of depreciation and amortization and $72K of share-based compensation. Working capital and other items used $754K. Capital expenditures of $9K left free cash flow of $2.9M.
Questions
What was Utah Medical Products' revenue in the fourth quarter 2024?
Utah Medical Products (UTMD) reported revenue of $9.2M for the fourth quarter 2024 (Q4 2024), -26% from a year earlier and -8% from the quarter before.
Was Utah Medical Products profitable in the fourth quarter 2024?
Operating profit was $2.9M (32.0% of revenue) and net earnings $2.9M.